DENVER, Oct. 22, 2010 (GLOBE NEWSWIRE) -- MusclePharm® Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in its portfolio of performance products, today announced UFC star Jake Shields will be wearing MusclePharm apparel at the UFC 121 co-main event, which takes place on October 23 from the Honda Center in Anaheim, California.
UFC 121 Matches draw an estimated 850,000 pay per view buys and is watched by an estimated 10 million viewers.
"UFC has been a tremendous partner for our company, and the exposure we will receive Saturday night addresses the perfect demographic for our brand. We are very excited to have one of our MMA athletes featured as the co-main event," commented Cory Gregory, MusclePharm's President. "This branding opportunity with UFC will further increase MusclePharm's brand awareness and expand MusclePharm's supplement and apparel market penetration."
Shields (25-4-1) is in the midst of an impressive 14-fight win streak, with wins over decorated veterans including Yushin Okami, Carlos Condit, Paul Daley, Robbie Lawler, Jason "Mayhem" Miller and Dan Henderson during that stretch.
In his last fight, which took place under the Strikeforce banner, he defeated Henderson by decision. It was the last fight under his contract, however, and despite being the Strikeforce middleweight champ, he abandoned the belt to sign with the UFC as a free agent. Upon moving to the UFC, he returned to the 170-pound division, in which he's spent most of his career.
Jake Shields is the number 1 contender at 170 weight class, and with a win Saturday night he is expected to be next in line for the title shot.
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that developments and manufacturers a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's proprietary and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com. For more information, please visit .
MusclePharm Corporation believes the information set forth in this Press Release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Certain factors that could cause results to differ materially from those projected in the forward-looking statements are set forth in "Risk Factors" in Item 2.02 of the Company's Form 8-K dated February 18, 2010, which has been filed with the Securities and Exchange Commission.
CONTACT: ICR Investor Contact: John Mills, Senior Managing Director 310.954.1105